Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Thoracic 1 Lymphoid 1 Breast 1

Conditions

Thymoma 1 Thymic epithelial tumor 1

Interventions

Carboplatin 195 pembrolizumab 158 Pemetrexed 136 Cisplatin 119 durvalumab 73 Paclitaxel 72 osimertinib 68 Nivolumab 66 Docetaxel 63 Specimen Handling 61 atezolizumab 58 Magnetic Resonance Spectroscopy 50 Etoposide 47 Gemcitabine 42 Radiotherapy 39 Radiosurgery 37 130-nm albumin-bound paclitaxel 34 Drug Therapy 30 Cetuximab 28 Bevacizumab 27 Ipilimumab 25 Taxes 23 cemiplimab 22 tislelizumab 21 Platinum 20 Radiation 19 amivantamab 18 Immunoglobulin G 17 1,2-diaminocyclohexaneplatinum II citrate 17 Disulfides 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

AP 1903 reagent × Thoracic × 90 days × Clear all

NCT07598955 2026-05-20

SELECT-NK-THYM

Beijing Biotech

Phase 1/2 Recruiting

Thymic epithelial tumor, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡